Medical News

RSS

Obama to pitch health care law in Iowa

President Obama Thursday will try to convince a wavering public that a new health care reform law will benefit their lives as he travels to Iowa City for a rally where he first called for health care legislation as a presidential candidate.

26 Mar 2010

Aastrom Biosciences' RESTORE-CLI trial: Final patient treated

Aastrom Biosciences, Inc., a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported that the final patient has been treated in the company's ongoing multi-center, randomized, double-blind, placebo-controlled U.S. Phase 2b clinical trial designated RESTORE-CLI. This patient received intramuscular injections of either Aastrom's tissue repair cells (TRCs) or electrolyte solution (placebo) for the treatment of critical limb ischemia (CLI), the end-stage of peripheral arterial disease.

26 Mar 2010

Human rights organization calls for national action to combat rising pregnancy-related complications

Amnesty International today pointed to new government figures showing the highest-ever rate of Caesarean sections as more evidence the United States needs to adopt guidelines for the use of obstetric procedures to begin reversing rising pregnancy complications and maternal deaths.

26 Mar 2010

EVMS researchers awarded $1,076,250 grant to develop functional cure for Type 1 diabetes

Researchers at the Eastern Virginia Medical School Strelitz Diabetes Center have been awarded a $1,076,250 grant by the Department of Defense Peer Reviewed Medical Research Program to develop new ways of reversing the underlying causes of Type 1 diabetes.

26 Mar 2010

IMRISNV and IMRIScardio systems get Australian TGA clearance

IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.

26 Mar 2010

It's over: House passes last piece of landmark health reform, 220-207

Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).

26 Mar 2010

DARA BioSciences announces the initiation of Phase I clinical study for DB959

DARA BioSciences, Inc. announced that it has initiated a Phase I clinical study for DB959, its PPAR (peroxisome proliferator activated receptor) delta/gamma agonist, an oral drug in development for the treatment of Type 2 Diabetes. The study will enroll approximately 75 volunteers and will be conducted at Quintiles' Overland Park facility.

26 Mar 2010

Palex Medical to distribute Genomic Health's Oncotype DX breast cancer test in Spain and Portugal

Genomic Health, Inc. today announced that the company has entered into an exclusive agreement with Palex Medical S.A., one of Europe's leading distributors of medical device and diagnostic services to hospitals, to distribute its Oncotype DX® breast cancer test in Spain and Portugal. The distribution agreement, announced in conjunction with positive data presented today at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for increased physician and patient access to this advanced diagnostic test in the European market.

26 Mar 2010

CorMedix announces pricing of initial public offering of 1,925,000 units at $6.50 per unit

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease, today announced the pricing of its initial public offering of 1,925,000 units at $6.50 per unit (before underwriting discounts and commissions).

26 Mar 2010

Medicare Roundup: Changes from health reform, payments for HIV patients

USA Today: "Perhaps the biggest factor in whether your Medicare costs will rise or fall depends on your Medicare plan. There are two: a traditional Medicare plan run by the federal government and Medicare Advantage, which is run by private insurance companies. Medicare Advantage costs more than the traditional plan, but provides more generous benefits.

26 Mar 2010

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Millions of patients with high blood pressure and heart failure take a class of drugs known as ACE (angiotensin-converting enzyme) inhibitors. These drugs prevent the body from processing angiotensin II, a hormone that constricts blood vessels.

26 Mar 2010

Medicare pay cut for doctors still looms at end of month

"A health care overhaul may now be in place, but a pay cut for Medicare reimbursements to physicians looms again at the end of the month, and the president-elect of the American Medical Association said Wednesday that doctors are continuing to pursue a permanent fix for the system," CQ Health Beat reports.

26 Mar 2010

VisEn Medical announces launch of new GastroSense 750 fluorescence agent for imaging gastric motility

VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.

26 Mar 2010

Natural chemicals from blackcurrants may reduce lung inflammation in allergy-induced asthma

A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.

26 Mar 2010

JCOM receives approval from KFDA to commercialize MuGard in Korea

ACCESS PHARMACEUTICALS, INC. announced that JCOM Co., Ltd., its Korean licensee for both MuGard™ and ProLindac™, has received approval from the Korean Food and Drug Administration of its Registration Dossier for MuGard, an oncology supportive-care treatment for the management of oral mucositis.

26 Mar 2010

Sexual abuse in childhood triggers retraumatization during pregnancy

A new study carried out by Prof. Rachel Lev-Wiesel and Dr. Tzachi Ben Zion has found that women who were victims of sexual abuse in childhood reported higher levels of depression and symptoms of post-trauma during pregnancy.

26 Mar 2010

Comparative effectiveness research in reform legislation seeks to control health costs

Within the health bill is an element that "has generated far less attention and political heat than other parts of the White House's plan to expand medical coverage to 32 million uninsured Americans.

26 Mar 2010

BioScrip acquires Critical Homecare Solutions Holdings

BioScrip, Inc. today announced that it has completed its acquisition of Critical Homecare Solutions Holdings, Inc. (“CHS”), a leading provider of home infusion and home nursing products and services to patients suffering from chronic and acute medical conditions.

26 Mar 2010

Body lice and head lice have same origin

Body lice, which cause highly lethal epidemics (trench fever, typhus and relapsing fever Borrelia), originate from head lice. This has recently been shown by a team from the Emerging Infectious and Tropical Diseases Research Unit (CNRS/IRD/Université de la Méditerranée), in collaboration with researchers from the Universities of Florida and Illinois (US).

26 Mar 2010

New initiative to reduce prescription drug abuse

With overdoses and deaths involving the use of prescription drugs skyrocketing in the United States, the Department of Justice (DOJ) has selected the Heller School for Social Policy and Management at Brandeis University to host a new initiative to reduce diversion and abuse of these drugs: the PMP Center of Excellence.

26 Mar 2010

Medical News

Obama to pitch health care law in Iowa

Aastrom Biosciences' RESTORE-CLI trial: Final patient treated

Human rights organization calls for national action to combat rising pregnancy-related complications

EVMS researchers awarded $1,076,250 grant to develop functional cure for Type 1 diabetes

IMRISNV and IMRIScardio systems get Australian TGA clearance

It's over: House passes last piece of landmark health reform, 220-207

DARA BioSciences announces the initiation of Phase I clinical study for DB959

Palex Medical to distribute Genomic Health's Oncotype DX breast cancer test in Spain and Portugal

CorMedix announces pricing of initial public offering of 1,925,000 units at $6.50 per unit

Medicare Roundup: Changes from health reform, payments for HIV patients

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Medicare pay cut for doctors still looms at end of month

VisEn Medical announces launch of new GastroSense 750 fluorescence agent for imaging gastric motility

Natural chemicals from blackcurrants may reduce lung inflammation in allergy-induced asthma

JCOM receives approval from KFDA to commercialize MuGard in Korea

Sexual abuse in childhood triggers retraumatization during pregnancy

Comparative effectiveness research in reform legislation seeks to control health costs

BioScrip acquires Critical Homecare Solutions Holdings

Body lice and head lice have same origin

New initiative to reduce prescription drug abuse

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News